Delivery Order SPE2DB20D2104-SPE2DB25F1430
Award Date
11/6/24
Potential Completion Date
11/7/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FETQZ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,081.43 firm-fixed-price delivery order covers the supply of Dupixent 300 mg/2 ml pen for a period ending on January 31, 2025. This contract is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,095.78 firm-fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of January 11, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, with the ID SPE2DB20D1004|SPE2DB25FNELL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,822.07 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialized pharmaceutical product, with a completion date of January 27, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,652.35 delivery order contract is for the supply of Dupixent 200 mg/1.14 ml pen medical products. The contract has an ultimate completion date of August 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,965.24 firm-fixed-price delivery order is for the supply of the specialty medication Dupixent 300 mg/2 ml pen. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,117.64 firm fixed-price delivery order is for the supply of 4,566,529,682 units of the drug Dupixent 300 mg/2 ml pen. The contract has a completion date of November 25, 2024 and was awarded on November 22, 2024. This award is associated with AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,367.74, is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. The contract covers the supply of Dupixent 300 mg/2 ml pens, a medication used for various medical conditions. This award is associated with a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,457.59 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,702.09 Firm Fixed Price Delivery Order contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty medication. The contract has an ultimate completion date of June 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,228.32 awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of the prescription medication Dupixent 300 mg/2 ml pen, with a period of performance ending on August 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999...